Search research articles

Related Concept Videos

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor.

Current opinion in hematology·2018

Same author

Long-Term Effects of G-CSF Therapy in Cyclic Neutropenia.

The New England journal of medicine·2017

Same author

Somatic mutations and clonal hematopoiesis in congenital neutropenia.

Blood·2017

Same author

Use of granulocyte colony-stimulating factor during pregnancy in women with chronic neutropenia.

Obstetrics and gynecology·2015

Same author

The diversity of mutations and clinical outcomes for ELANE-associated neutropenia.

Current opinion in hematology·2014

Same author

TCIRG1-associated congenital neutropenia.

Human mutation·2014

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: May 16, 2026

Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay

Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay

Published on: May 12, 2023

How to approach neutropenia.

Laurence A Boxer¹

¹Department of Pediatrics and Communicable Diseases, University of Michigan Health System, Ann Arbor, MI 48109-5718, USA. laboxer@umich.edu

Hematology. American Society of Hematology. Education Program

|December 13, 2012

Summary

Neutropenia, a low neutrophil count, can be acute and transient or chronic, increasing infection risk. Rare genetic defects in neutrophil production are linked to serious conditions like leukemia.

Area of Science:

Hematology
Immunology
Genetics

Background:

Neutropenia is a reduced absolute neutrophil count, with acute forms being common and often self-resolving.
Chronic neutropenia, lasting over three months, results from decreased production, increased destruction, or splenic sequestration.
Neutropenia can be secondary to external factors, an acquired myeloid progenitor disorder, or a rare intrinsic defect.

Purpose of the Study:

To define neutropenia and its classifications.
To highlight the significance of neutropenia arising from hematologic disorders.
To discuss the implications of severe neutropenia and genetic defects.

Main Methods:

Literature review and synthesis of existing knowledge on neutropenia.
Classification of neutropenia based on duration, cause, and origin.

More Related Videos

A Set of Screening Techniques for a Quick Overview of the Neutrophil Function

A Set of Screening Techniques for a Quick Overview of the Neutrophil Function

Published on: February 9, 2024

Related Experiment Videos

Last Updated: May 16, 2026

Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay

Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay

Published on: May 12, 2023

A Set of Screening Techniques for a Quick Overview of the Neutrophil Function

A Set of Screening Techniques for a Quick Overview of the Neutrophil Function

Published on: February 9, 2024

Discussion of diagnostic considerations and associated risks.

Main Results:

Acute neutropenia is frequent and usually benign, while chronic neutropenia poses greater risks.
Severe neutropenia (ANC < 500/μL) significantly elevates susceptibility to bacterial and fungal infections.
Genetic defects in severe congenital neutropenia impact neutrophil precursor differentiation, adhesion, and apoptosis.

Conclusions:

Neutropenia requires thorough investigation, especially when linked to hematologic disorders.
Understanding genetic defects provides insights into neutrophil biology and associated risks like myelodysplasia and acute myeloid leukemia.
Severe neutropenia necessitates prompt management to mitigate infectious complications.